17 MARCH 2010
NORTHERN VENTURE TRUST PLC ("The Company")
PURCHASE OF OWN SHARES AND TOTAL VOTING RIGHTS
The Company announces that on 13 January 2010 it purchased for cancellation
under an authority granted by shareholders at the annual general meeting held on
13 January 2010 all of its 42,219,238 deferred shares of 25p each for an
aggregate consideration of 43p.
In conformity with the Transparency Directive, the Company notifies the market
that the capital of the Company consists of 59,339,418 ordinary shares with a
nominal value of 25p each, with voting rights.
The Company does not hold any ordinary shares in treasury.
Therefore, the total number of voting rights in the Company is 59,339,418 (the
"Figure").
The Figure may be used by a shareholder or other person as the denominator for
the calculations by which he will determine if he is required to notify the
voting rights he holds in relation to the Company, or a change to those voting
rights, under the FSA's Disclosure and Transparency Rules.
Enquiries:
Alastair Conn/Christopher Mellor, NVM Private Equity Limited - 0191 244 6000
Website:Â www.nvm.co.uk <
http://www.nvm.co.uk/>
[HUG#1394901]
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.